These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10857708)

  • 1. The effects of nicotine on Parkinson's disease.
    Kelton MC; Kahn HJ; Conrath CL; Newhouse PA
    Brain Cogn; 2000; 43(1-3):274-82. PubMed ID: 10857708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
    Lemay S; Chouinard S; Blanchet P; Masson H; Soland V; Beuter A; Bédard MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):31-9. PubMed ID: 14687854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding?
    Yogev G; Giladi N; Peretz C; Springer S; Simon ES; Hausdorff JM
    Eur J Neurosci; 2005 Sep; 22(5):1248-56. PubMed ID: 16176368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
    J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine effects on general semantic priming in Parkinson's disease.
    Holmes AD; Copland DA; Silburn PA; Chenery HJ
    Exp Clin Psychopharmacol; 2011 Jun; 19(3):215-23. PubMed ID: 21480732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
    Poltavski DV; Petros T
    Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.
    York MK; Lai EC; Jankovic J; Macias A; Atassi F; Levin HS; Grossman RG
    Acta Neurochir (Wien); 2007; 149(9):857-66; discussion 866. PubMed ID: 17624489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicotinic stimulation on cognitive performance.
    Newhouse PA; Potter A; Singh A
    Curr Opin Pharmacol; 2004 Feb; 4(1):36-46. PubMed ID: 15018837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does implicit learning in non-demented Parkinson's disease depend on the level of cognitive functioning?
    Vandenbossche J; Deroost N; Soetens E; Kerckhofs E
    Brain Cogn; 2009 Feb; 69(1):194-9. PubMed ID: 18715683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response.
    Arthur D; Levin ED
    Psychopharmacology (Berl); 2002 Mar; 160(2):140-5. PubMed ID: 11875631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
    Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalamic stimulation for tremor. Subtle changes in episodic memory are related to stimulation per se and not to a microthalamotomy effect.
    Loher TJ; Gutbrod K; Fravi NL; Pohle T; Burgunder JM; Krauss JK
    J Neurol; 2003 Jun; 250(6):707-13. PubMed ID: 12796834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism].
    Ruiz-Rizzo AL; Tirado V; Moreno-Carrillo C; Aguirre-Acevedo DC; Murillo O; Lopera F
    Rev Neurol; 2009 Aug 1-15; 49(3):123-30. PubMed ID: 19621306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.